Invention Grant
![3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide derivatives](/docs/US/2023-01-03/US11541056B2/abs.jpg.600x600.jpg)
- Patent Title: 3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide derivatives
-
Application No.: US16981208Application Date: 2019-03-25
-
Publication No.: US11541056B2Publication Date: 2023-01-03
- Inventor: Luca Arista , Christina Hebach , Gregory John Hollingworth , Philipp Holzer , Patricia Imbach-Weese , Rainer Machauer , Niko Schmiedeberg , Anna Vulpetti , Thomas Zoller
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Priority: EP18164085 20180326
- International Application: PCT/IB2019/052392 WO 20190325
- International Announcement: WO2019/186358 WO 20191003
- Main IPC: C07D519/00
- IPC: C07D519/00 ; C07D487/04 ; A61K31/519 ; A61P35/00
![3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide derivatives](/abs-image/US/2023/01/03/US11541056B2/abs.jpg.150x150.jpg)
Abstract:
The invention relates to compounds of the formula (I) or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined in the specification; to intermediates in the preparation of the compounds, to pharmaceutical compositions comprising the compounds and to use of the compounds in the treatment of disease.
Public/Granted literature
- US20210251996A1 3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide Derivatives Public/Granted day:2021-08-19
Information query
